Advances in Lymphoma Treatment Through Targeted Therapy

| Comments (0)

Anas Younes, M.D., director of Clinical and Translational Investigation in the Department of Lymphoma/Myeloma at M. D. Anderson, takes us into his lab where he's researching new targeted therapies for people with Hodgkin and non-Hodgkin lymphoma. His focus is on identifying opportunities to cause cell death or slow the growth of cells for certain tumor types.

He identifies the process involved in getting these targeted therapy drug combinations from the lab into Phase I clinical trials and eventually into standard treatment. 

Younes.jpgAnas Younes, M.D., is a professor in the Department of Lymphoma/Myeloma in the Division of Cancer Medicine. For more information about targeted therapies for lymphoma, you can contact Younes via e-mail, Facebook or Twitter.

Follow DrAnasYounes on Twitter
Become a fan of Dr. Younes on Facebook

Leave a comment


Connect on social media

Sign In